Results 21 to 30 of about 99,522,423 (293)
N- and O-Glycosylation of the SARS-CoV-2 Spike Protein [PDF]
ABSTRACT Covid-19 pandemic outbreak is the reason of the current world health crisis. The development of effective antiviral compounds and vaccines requires detailed descriptive studies of the SARS-CoV-2 proteins. The SARS-CoV-2 spike (S) protein mediates virion binding to the human cells through its interaction with the ACE2 cell ...
Sanda, Miloslav +2 more
openaire +4 more sources
The SARS-CoV-2 spike protein: balancing stability and infectivity [PDF]
SARS-CoV-2 spike (S) glycoprotein is the key target of current vaccine development efforts to combat COVID-19; neutralizing antibodies bind S and interfere with S binding to its receptor, angiotensin-converting enzyme 2. Recent work reveals the molecular basis of increased infectivity of the globally prevailing D614G S mutation.
Berger, Imre, Schaffitzel, Christiane
openaire +3 more sources
A thermostable, closed, SARS-CoV-2 spike protein trimer [PDF]
Abstract The spike (S) protein of SARS-CoV-2 mediates receptor binding and cell entry and is the dominant target of the immune system. S exhibits substantial conformational flexibility. It transitions from closed to open conformations to expose its receptor binding site, and subsequently from prefusion to postfusion conformations to ...
Xiong, X. +87 more
openaire +5 more sources
SARS-CoV-2 Spike Protein Interaction Space
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a +sense single-strand RNA virus. The virus has four major surface proteins: spike (S), envelope (E), membrane (M), and nucleocapsid (N), respectively. The constitutive proteins present a high grade of symmetry. Identifying a binding site is difficult. The virion is approximately 50–200 nm
Claudiu N. Lungu, Mihai V. Putz
openaire +2 more sources
O-Glycosylation Landscapes of SARS-CoV-2 Spike Proteins [PDF]
The densely glycosylated spike (S) proteins that are highly exposed on the surface of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) facilitate viral attachment, entry, and membrane fusion. We have previously reported all the 22 N -glycosites and site-specific
Yong Zhang +10 more
openaire +3 more sources
SARs-Cov-2 spike protein and ACE2
Model built as part of a collaborative molecular simulation SARS-COv-2 project investigating the interactions between the SARS-CoV-2 spike protein and ACE2 protein, each component being embedded in its lipid bilayer.
Laurent Chaloin (12269174) +2 more
core +1 more source
Distinct conformational states of SARS-CoV-2 spike protein [PDF]
A dynamic viral spike Efforts to protect human cells against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have focused on the trimeric spike (S) protein. Several structures have shown a stabilized ectodomain of the spike in its prefusion conformation. Cai et al.
Yongfei Cai +8 more
openaire +3 more sources
Allosteric Regulation of SARS-CoV-2 Spike Protein Revealed by Contrastive Machine Learning [PDF]
Allosteric regulation is common in protein-protein interactions and thus can be used in drug design. Nevertheless, the mechanism of allosteric regulation remains elusive for most proteins, including SARS-CoV-2 spike protein, despite extensive ...
Tao, Wei +9 more
core +1 more source
Sars-Cov-2 And Betacoronavirus: What Have We Learned In 8 Months?
In 2019, a new human pandemic coronavirus (SARS-CoV-2) emerged in Wuhan, China. We present the knowledge about SARS-CoV-2 compared to SARS-CoV and MERS-CoV. The SARS-CoV-2 is similar to other coronaviruses, nevertheless, differences were observed.
Kwiatek Agnieszka +1 more
doaj +1 more source
Summary: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants poses continuous challenges in combating the virus. Here, we describe vaccination strategies to broaden SARS-CoV-2 and sarbecovirus immunity by combining ...
Mitch Brinkkemper +20 more
doaj +1 more source

